North Brunswick, NJ, September 5, 2008: ProFACT Proteomics, Inc. has appointed two new sales agents to canvas exclusive territories promoting its functional proteomic services: Robert Jones, Ph.D. for Pennsylvania (Tel: 570-449-0103), and Millennium Technologies and Services for the midwestern US states along with Ontario and Quebec provinces in Canada (Tel: 216-374-8687).
About ProFACT Proteomics, Inc.
ProFACT Proteomics, Inc. is a privately held early-stage corporation which applies its enabling proprietary Proteomics technology, for development of therapeutics, diagnostics and personalized medicine, principally for cancer. Through partnership and service agreements, ProFACT participates in 4 key platform areas: SeraFILE™, for reduction of protein complexity and sub-proteome creation; Rational Proteome Prospecting™, to enrich and isolate functional activity; Conformerics™, to generate drug screening assays based on enzyme sub-states or conformers; and Rational Genome to Proteome Prospecting™, for prospecting into protein expression based on gene expression data.
